In summary, SMYD3 plays critical roles in bladder cancer oncogenesis, such as interactions with IGF-1R and AKT/mTOR in a possible feedback pathway, cell cycle and apoptotic regulation, and autophagy activation via BCLAF1 regulation. Here, SMYD3 is linked to urinary bladder carcinoma.